Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-04

Clinical Trial Update: Effect of Tegaserod on Orocecal Transit in Elderly Chronic Constipation Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating tegaserod's effect on orocecal transit in elderly adults with chronic constipation. The study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tegaserod (tegaserod)

Snippet

Sponsor: Novartis | Conditions: Chronic Constipation | Phase 4 | Status: TERMINATED